Matthew Winkler insider trades

Open-market stock purchases and sales by Matthew Winkler, Director at Akoya Biosciences, Inc, from SEC Form 4 filings since Sep 30, 2015.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • AKYA Akoya Biosciences, Inc: 1 buy, last Jul 8, 2025
  • MIRN Mirna Therapeutics, Inc: other filings, last Jun 29, 2016

Get free alerts when Matthew Winkler files a new trade →